FindTrial
Sign In

Effect of NTCP*2 Polymoorphism on Rosuvastain Pharmacoknitics in Healthy Chinese Han Males

Effect of NTCP*2 Polymoorphism on Rosuvastain Pharmacoknitics in Healthy Chinese Han Males

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RO-12002886
Enrollment
Unknown
Registered
2012-12-09
Start date
2011-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

1:Nil

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
19 Years to 28 Years

Inclusion criteria

Inclusion criteria: Genotype of NTCP*2

Exclusion criteria

Exclusion criteria: Genotype of CYP2C9*3, OATP1B1*5?BCRP 421C>A

Design outcomes

Primary

MeasureTime frame
plasma drug concentration;—

Contacts

Public ContactHonghao Zhou
hhzhou2003@163.com+86 0731-84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026